Cresco Labs (OTCMKTS:CRLBF) Upgraded by Cormark to "Moderate Buy" Rating

Cormark upgraded shares of Cresco Labs (OTCMKTS:CRLBF - Free Report) from a hold rating to a moderate buy rating in a report published on Monday morning,Zacks.com reports. Cormark also issued estimates for Cresco Labs' FY2025 earnings at ($0.07) EPS and FY2026 earnings at $0.01 EPS.

Separately, Atb Cap Markets downgraded Cresco Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, December 9th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $3.00.

Cresco Labs Price Performance

OTCMKTS:CRLBF traded down $0.00 during mid-day trading on Monday, reaching $0.73. The stock had a trading volume of 281,878 shares, compared to its average volume of 608,755. The firm has a 50 day moving average price of $0.86 and a two-hundred day moving average price of $1.17. The stock has a market capitalization of $356.34 million, a P/E ratio of -3.65 and a beta of 1.79. Cresco Labs has a one year low of $0.69 and a one year high of $2.60. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97.

Remove Ads

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last released its earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The company had revenue of $176.00 million during the quarter, compared to the consensus estimate of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. As a group, analysts expect that Cresco Labs will post -0.2 earnings per share for the current year.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.